Page last updated: 2024-08-24

3-iodobenzylguanidine and su 11248

3-iodobenzylguanidine has been researched along with su 11248 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Makis, W; McCann, K; McEwan, AJ; Sawyer, MB	1

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and su 11248

Article	Year
Combined Treatment With 131I-MIBG and Sunitinib Induces Remission in a Patient With Metastatic Paraganglioma Due to Hereditary Paraganglioma-Pheochromocytoma Syndrome From an SDHB Mutation. Clinical nuclear medicine, 2016, Volume: 41, Issue:3 Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Bone Neoplasms; Chemoradiotherapy; Female; Humans; Indoles; Mutation; Pheochromocytoma; Pyrroles; Remission Induction; Succinate Dehydrogenase; Sunitinib	2016

Article

Year

Combined Treatment With 131I-MIBG and Sunitinib Induces Remission in a Patient With Metastatic Paraganglioma Due to Hereditary Paraganglioma-Pheochromocytoma Syndrome From an SDHB Mutation.

Clinical nuclear medicine, 2016, Volume: 41, Issue:3

Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Bone Neoplasms; Chemoradiotherapy; Female; Humans; Indoles; Mutation; Pheochromocytoma; Pyrroles; Remission Induction; Succinate Dehydrogenase; Sunitinib

2016